黄豆苷元自微乳化半固体骨架胶囊制备及大鼠体内药动学研究  

Preparation of self-microemulsifying semi-solid matrix hard capsules of daidzein and its pharmacokinetics in rats

在线阅读下载全文

作  者:崔文奇[1] 王东凯[1] 韩晓[1] 张春叶[1] 李翔[1] 张晓君[1] 

机构地区:[1]沈阳药科大学药学院,沈阳110016

出  处:《中国新药杂志》2010年第18期1714-1718,共5页Chinese Journal of New Drugs

摘  要:目的:制备黄豆苷元自微乳化半固体骨架胶囊,并考察其在大鼠体内药动学行为。方法:制备药物的过饱和溶液以测定药物在各种油、表面活性剂及助表面活性剂中的溶解度,采用伪三元相图法筛选表面活性剂与助表面活性剂的比例;通过正交设计优化处方并考察了大鼠经灌胃后体内药动学情况。结果:优化后的处方各组分比为DA(1.5)∶LM1944CS(10)∶聚山梨酯(Tween-80)/Transcutol(4∶1)(50)∶S-40(20)。黄豆苷元自微乳化半固体骨架胶囊与市售胶囊的相对生物利用度为(256.0±26.0)%。结论:按优化后处方制得黄豆苷元自微乳化半固体骨架释药系统可显著提高其生物利用度。Objective: To prepare daidzein self-microemulsifying hard capsules drug delivery system and to investigate its pharmacokinetic profiles in SD rats.Methods: The optimum formulations of daidzein self-microemulsifying hard capsules were screened by solubility experiments,pseudo-ternary phase diagrams and orthogonal design.Pharmacokinetic profiles after oral administration were investigated in SD rats.Results: The optimum daidzein self-microemulsifying hard capsules were composed of daidzein(1.5)∶LM1944CS(10)∶Tween-80/Transcutol(4∶1)(50)∶S-40(20).The relative bioavailability between DA-SMEDDS and DA capsule was(256.0±26.0)%.Conclusion: Daidzein self-microemulsifying hard capsules can be prepared according to the optimum formulations and the bioavailability is dramatically increased.

关 键 词:黄豆苷元 自微乳化 半固体 药动学 

分 类 号:R943.4[医药卫生—药剂学] R972.4[医药卫生—药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象